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Background: Illness-related stigma has attracted considerable research interest, but few studies have specifically
examined stigmatisation of cancer in the non-patient population. The present study developed and validated a
Cancer Stigma Scale (CASS) for use in the general population.
Methods: An item pool was developed on the basis of previous research into illness-related stigma in the
general population and patients with cancer. Two studies were carried out. The first study used Exploratory
factor analysis to explore the structure of items in a sample of 462 postgraduate students recruited through a
London university. The second study used Confirmatory factor analysis to confirm the structure among 238
adults recruited through an online market research panel. Internal reliability, test-retest reliability and construct
validity were also assessed.
Results: Exploratory factor analysis suggested six subscales, representing: Awkwardness, Severity, Avoidance,
Policy Opposition, Personal Responsibility and Financial Discrimination. Confirmatory factor analysis confirmed
this structure with a 25-item scale. All subscales showed adequate to good internal and test-retest reliability in
both samples. Construct validity was also good, with mean scores for each subscale varying in the expected
directions by age, gender, experience of cancer, awareness of lifestyle risk factors for cancer, and social desirability.
Means for the subscales were consistent across the two samples.
Conclusions: These findings highlight the complexity of cancer stigma and provide the Cancer Stigma Scale (CASS)
which can be used to compare populations, types of cancer and evaluate the effects of interventions designed to
reduce cancer stigma in non-patient populations.
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Stigma is an attribute that discredits a person, reducing
them “from a whole and usual person to a tainted, dis-
counted one” (p.12) [1]. This highlights two important
components of stigma: the characteristic that makes a
person ‘different’ and the devaluation of the person on
the basis of this difference [2]. Health-related stigma refers
to stigmatisation of an illness, which can be applied to an
individual or a group of people with the illness, as well as
to the illness more generally [3]. It is “characterized by ex-
clusion, rejection, blame or devaluation that results from
experience, perception or reasonable anticipation of an
adverse social judgment about a person or group” (p.280)* Correspondence: l.marlow@ucl.ac.uk
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article, unless otherwise stated.[4]. There is widespread agreement that illness stigmatisa-
tion is not stable, but influenced by social attitudes that
differ across cultures and change over time [5].
Most of the literature exploring health-related stigma
has focused on a small group of illnesses: leprosy, epilepsy,
HIV/AIDS and mental illness [6]. Cancer has attracted
less research attention, although it is often described as a
stigmatised condition (http://livestrongblog.org/2010/02/
01/cancer-stigma), and perceptions of stigma have been
identified as a concern among cancer patients. Patients
sometimes feel avoided by others once they have received
a cancer diagnosis [7-9] and fear of stigmatisation can
be a barrier to disclosure of a cancer diagnosis [8,10].
Work exploring stigma among cancer patients has focused
on lung cancer, with patients who are smokers feelingCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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inflicted [11].
Few studies have explored stigma towards cancer in
the non-patient population, although there are several
reasons why this is important. The availability of cancer
detection and prevention procedures (e.g. screening and
HPV vaccination) means that people need to consider the
possibility of a cancer diagnosis in the context of making
preventive health decisions and fear of stigmatisation has
been identified as a potential barrier to self-examination,
screening, and delayed presentation of cancer symptoms
[12-18]. It is also possible that the growing number of
public health campaigns designed to educate the public
about behavioural risk factors for cancer (e.g. smoking,
obesity, Human Papillomavirus) could generate stigma by
implying that cancers are avoidable [11].
The aim of the present study was to develop a Cancer
Stigma Scale (CASS) for use in non-patient populations.
Being able to measure the stigma of cancer would make
it possible to identify the extent to which stigma exists,
to monitor changes in perceptions of cancer as a result
of public health campaigns or media attention and to
help identify risk factors for more stigmatised beliefs.
A multidimensional concept
Stigma is considered to be a multidimensional concept.
Jones et al. identified six components of health-related
stigma which apply to varying degrees depending on the
illness of interest [19]. The first component, ‘peril’, relates
to perceived danger from the stigmatised person, for ex-
ample if their illness is considered contagious (e.g. HIV/
AIDs) or they are considered dangerous (e.g. some men-
tal illnesses). Interacting with those who are ill also
raises awareness of personal mortality, resulting in anx-
iety and the need to see those who have the illness as
different [20]. This side of peril is particularly relevant to
cancer: ‘[The] dying cancer patient may make us starkly
and disagreeably aware that a similar fate can befall us’
(p.66, [19]).
The second component, ‘course’ , refers to changes in
the illness over time, with conditions that are progres-
sively crippling, chronic and incurable being more stig-
matised. This is similar to the component of ‘stability’ ,
identified by others [21]. If beliefs about the success of
cancer treatments become more optimistic and the chances
of long-term survivorship are seen as higher, the course-
related element of stigma could be reduced.
The third component is ‘origin’. This relates to when
and how the illness is believed to have come about. A
particularly relevant aspect of this is the attributions of
perceived responsibility, because when a person is be-
lieved to have caused their illness, the associated stigma
is greater [19]. Again this is supported by other stigma
theorists [5,21]. It may become increasingly relevant forcancer as the lifestyle determinants are more widely recog-
nized. There is already evidence that lung cancer patients
believe that the well-established link between smoking
and their type of cancer contributes to stigmatisation [8],
and more blame is attributed to patients with lung cancer
than patients with leukaemia, breast, bowel or cervical
cancer [22].
The three remaining components are ‘concealability’
(whether an illness can be hidden from others), ‘disruptive-
ness’ (whether it disrupts usual interactions), and ‘aesthetics’
(described as a primitive response by the perceiver to a
non-concealable mark that makes the person less ‘pleasing
on the eye’). Similar aspects are identified by other theorists,
including Crocker et al. [5] who suggested the ‘visability’
of a stigma creates a schema through which all other as-
pects of the person are viewed. Some cancers do not
have any visible signs, i.e. they are concealable. How-
ever, cancer treatment can result in more visible signs
such as alopecia or a colostomy bag, and several studies
have shown that these signs contribute to feelings of
stigmatisation [23,24].
These six components help to highlight the aspects of an
illness that may contribute to it being stigmatised. Each of
the components could be considered from the perspective
of the perceiver or the target [2]. Traditionally, studies
considering behavioral aspects of stigma have assessed
interpersonal avoidance and social distance [25-27], but
attitudes towards discrimination (e.g. employment law,
access to financial services) have also been considered
[28,29].
Measuring cancer-related stigma
In recent years there has been an increase in research
into perceptions of stigma among cancer patients, but
little systematic research into the general public’s atti-
tudes. In a review of 38 articles exploring stigma and
cancer, the majority focused on the cancer patient’s experi-
ence [30], with only seven studies in non-patient samples,
and these were mostly qualitative investigations. To our
knowledge, at the time of conducting this work no scales
were available for assessing cancer stigma in the non-
patient population. A 2006 review of illness-related stigma
identified 24 scales, but none of them assessed cancer-
related stigma [6]. Although these scales have traditionally
been used to indicate stigma, stigma of cancer was ex-
pected to be more subtle than with other illnesses and
many of the items traditionally used are unlikely to be
appropriate because of the non-contagiousness of cancer
(e.g. I would share a plate with someone with cancer).
Twenty years ago a measure of cancer attitudes was
developed that included some items related to stigma
(the Cancer Attitudes Inventory [31]; available in [32]).
However, it was designed to be unidimensional, and
did not reflect the different aspects of stigma that might
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Cancer Stigma Scale (CLCSS) was developed for lung can-
cer patients [33]. Adapted from an HIV Stigma Scale, the
CLCSS is a multidimensional measure with four subscales
assessing stigma and shame, social isolation, discrimin-
ation and smoking. We used a similar approach to de-
velop a multidimensional scale of cancer stigma, drawing
on measures of stigma in other illnesses and on the litera-
ture exploring perceptions of stigma in cancer patients.
Methods
Development of an item pool
An item pool was developed on the basis of previous re-
search into illness-related stigma in the general population
and patients with cancer. Illness-related stigma scales were
identified through a systematic review [6] that had used
the search terms ‘stigma’ or ‘discrimination,’ and ‘scales’ ,
‘measurement’ or ‘assessment’. Overall, 24 different mea-
sures had been used to assess stigma in the general popu-
lation, relating to leprosy, HIV/AIDS, mental illness,
epilepsy and skin disease. For five of the studies, we could
not access the scales, so items from 19 quantitative studies
were included in the item pool. Studies exploring percep-
tions of cancer-related stigma were identified through a
second systematic review [29] which used the search
terms ‘stigma and cancer’ , ‘stigma, psychosocial and can-
cer’ and ‘discrimination and cancer’. The review identified
38 studies of which three were not available, and 14 either
used indirect measures of stigma (e.g. GP referral or inter-
net use) or assessed a very specific area (e.g. attitudes to
HPV or alopecia). Relevant items were adapted from the
remaining 21 studies. Thirty-five items from the Cancer
Attitudes Inventory (CAI) were also included in the initial
item pool [31]. In total, 481 items were extracted from 41
studies that had used qualitative or quantitative methods
to assess stigma in patient and non-patient samples (see
Additional file 1).
Items were organized into themes and inspected to en-
sure that all relevant aspects of stigma (as identified by
Jones et al. 1980) were covered. Duplicate items were
deleted. The item pool was then discussed with a panel
of cancer researchers (n = 7, post-doctoral fellows and
senior researchers, with backgrounds in behavioural sci-
ence and psychology). The quality of each item was dis-
cussed in a single meeting following which further changes
were made to i) remove ambiguous items, ii) simplify
wording, iii) remove ‘loaded’ items, e.g. ‘suffering’ with
cancer and ‘cancer patient’ , iv) remove personalized items
e.g. ‘if I had cancer…’ , and v) ensure that there were some
positively worded items.
The refined item pool included 84 items. All attitude
items were phrased so that a 6-point response scale of
disagree strongly, disagree moderately, disagree slightly,
agree slightly, agree moderately and agree strongly, wouldbe appropriate. Response options for anticipated emo-
tional and behavioral reactions to someone with cancer
were definitely not, probably not, possibly not, yes pos-
sibly, yes probably and yes definitely. A ‘not sure’ option
was also offered for all items; this was positioned to the
right of the 6-point scale (rather than as a mid-point) and
was separated by a vertical dotted line to minimize the
chance of people using it because they wanted to avoid
thinking about the question.
The first item set was given to an opportunistic sample
(n = 57 students) to ensure that questions were answer-
able and wording was clear. This resulted in deletion of
two items because a large proportion of participants
(more than 20%) found them too difficult to answer.
Small changes were also made to the wording of sev-
eral items.aTesting the item pool
To explore the structure of the items and to test validity
and reliability, data were collected from two samples:
postgraduate students (study 1) and online panel partici-
pants (study 2). Both groups completed the questionnaire
online and anonymously. We chose this modality because
there is some suggestion that web-based data collection
can reduce the social desirability pressures of responding
to sensitive questions [34,35].Study 1 – Student sample
Methods A link to the questionnaire was sent via email
to all postgraduate students at a University in London.
Our target was to recruit a minimum of 300 students in
order to have a ‘good’ sample size for running factor ana-
lysis [36]. The online survey was closed two weeks after
the recruitment email was sent. Two to three weeks after
original completion of the questionnaire students were
sent a second email asking them to complete the survey
again for test-retest reliability. The email included an ID
number which they were asked to enter and this allowed
us to match the two sets of results. The study was
approved by the UCL Research Ethics Committee (ref:
0496/007). Students were offered entry into a prize draw
to win £100. Entry into an additional prize draw to win
£50 was offered for completing the survey a second time.
As well as completing the 82 stigma items, participants
completed i) the Level of Familiarity Questionnaire, ori-
ginally designed to assess familiarity with mental illness
[37] but adapted here for cancer, ii) a 10-item measure
of social desirability (The M-C 2(10), [38]), and iii) a
question from the Cancer Awareness Measure [39], which
asks participants to ‘put the following things in order of
how much you think they contribute to cancer’ (lifestyle,
chance, aging, environmental factors, and genetic inher-
itance). Based on findings from the stigma literature, we
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who were more familiar with the disease [37], and to be
higher in those who attributed cancer more strongly to
lifestyle [22]. Gender, age, and subject of study were also
reported. Based on the literature exploring stigma of
other illnesses, we expected stigma to vary by gender
and age [40,41].
Data were analyzed in SPSS version 15.0. Exploratory
factor analysis was used to examine the underlying factors
in the questionnaire. On the basis of these results, scales
assessing different aspects of cancer stigma were computed.
Internal reliability, test-retest reliability and construct
validity were assessed for each of the factors. Correla-
tions between factors were also examined.
Results Overall 473 postgraduate students completed the
questionnaire, of whom three quarters (72%) were female,
with a mean age of 29.1 (range 20–75). Current subject of
study was coded according to the university faculties list
and categorized into: arts and humanities (n = 144), en-
gineering and mathematics (n = 140), life sciences and
medicine (n = 181). A small proportion of respondents
reported that they had had cancer (3%), had lived with
someone who had cancer (7%), or had worked in a job
which involved providing services to someone with can-
cer (12%). The overwhelming majority responded yes to
the item ‘a friend of the family has had cancer’ or ‘I have
a relative who has cancer’ (91%). Fifteen percent had never
been around anyone with cancer. Lifestyle was rated as
the main cause of cancer by 37% of participants. Social
desirability was recoded into a binary variable for ease
of presentation, with 53% scoring low (mean: 0–5) and
47% high on social desirability (mean: 6–10).
Item distributions
Ten items were deleted because a large proportion of re-
spondents (more than 20%) indicated that they were un-
sure (i.e. they could not agree or disagree with the item).
According to Clark & Watson [42], it is important to in-
spect the distribution of individual items and delete items
that have a highly skewed distribution. Item distributions
were examined, and when fewer than 5% or more than
95% of respondents agreed, the item was excluded (a fur-
ther six items). Where >20% of the remaining 66 items
were missing, data from that respondent were excluded
from further analysis (n = 9).
Factor analysis
The 66 items were entered into a principal components
analysis. Inspection of the scree plot suggested that the
data were best represented by an 8-factor solution. This
accounted for 46% of the variance in the 66 items, and
the factors had eigenvalues of: 10.59, 6.36, 2.96, 2.76,
2.36, 1.98, 1.70 and 1.66. The Kaiser value was .86 andBartlett’s test was significant, indicating that factor ana-
lysis was appropriate. An oblique rotation (Promax) was
used, because the factors were expected to be correlated.
The eight factors assessed: Awkwardness (e.g. I would
find it difficult being around someone with cancer),
Severity (e.g. Once you’ve had cancer you’re never ‘normal’
again), Avoidance (e.g. I would distance myself physically
from someone with cancer), Policy Opposition (e.g.
More government funding should be spent on the care
and treatment of those with cancer, reversed), Personal Re-
sponsibility (e.g. A person with cancer is accountable for
their condition), Pity (e.g. I would feel sorry for someone
with cancer), Financial Discrimination (e.g. It is acceptable
for banks to refuse to make loans to people with cancer)
and Fear (e.g. Cancer is more frightening than most other
diseases).
Items loading < .4 or loading equally onto multiple factors
(with < .10 difference between the loadings) were rejected
(22 items). This included all items that loaded on the Fear
factor, all of which had low factor loadings (.33-.39), there-
fore Fear was not considered in further analyses. The item-
total correlations were inspected and one item was deleted
because the correlation was <0.3 [43]. At this stage we also
took the decision to exclude the Pity factor. Items assessing
pity were included in the initial item pool because previous
studies on stigma had included this construct. However, 2
of the 4 items remaining in this subscale had borderline
factor loadings (<.45) and the scale had a limited range.
Most respondents scored very highly (94% scored >4,
mean = 4.98, standard deviation = 0.74) and no-one scored
below 2. We therefore decided that pity was not appropri-
ately discriminating in the present scale.
Following these exclusions we were left with 39 items,
of which between 3 and 12 loaded on each of the remaining
six factors. To ensure the scale would not be too long and
to control participant burden, we excluded additional items
with the lowest factor loadings (for factors with multiple
items). Content validity was also taken into account, so in
one instance an item on the Avoidance subscale which
was considered important (I would try to avoid a person
with cancer, loading = .50) remained in place of one with a
slightly higher loading (I feel threatened by someone with
cancer, loading = .54).
The final scale included 26 items, with 3 to 5 asses-
sing: Awkwardness, Severity, Avoidance, Policy Opposition,
Personal Responsibility and Financial Discrimination (see
Table 1). Scores were calculated by taking the mean of
the final item list. These scores correlated highly with
Bartlett’s factor scores, supporting our decision to shorten
the scales (r = .93 to .98, p < .001). Figure 1 shows the
means and standard deviations for each factor. Higher
scores indicated more negative attitudes for all factors.
There were significant inter-correlations between most fac-
tors (see Table 2), ranging from small to medium, r = .11 to
Table 1 Exploratory factor analysis of stigma-related cancer
Factor
loading
Awkwardness
I would feel at ease around someone with cancer (R) −0.82
I would feel comfortable around someone
with cancer (R)
−0.80
I would find it difficult being around someone
with cancer
0.67
I would find it hard to talk to someone with cancer 0.67
I would feel embarrassed discussing cancer
with someone who had it
0.62
Severity
Once you’ve had cancer you’re never ‘normal’ again 0.78
Having cancer usually ruins a person’s Career 0.68
Getting cancer means having to mentally
prepare oneself for death
0.65
Cancer usually ruins close personal relationships 0.62
Cancer devastates the lives of those it touches 0.60
Avoidance
If a colleague had cancer I would try to avoid them 0.70
I would distance myself physically from
someone with cancer
0.68
I would feel irritated by someone with cancer 0.66
I would feel angered by someone with cancer 0.55
I would try to avoid a person with cancer 0.50
Policy opposition
More government funding should be spent on
the care and treatment of those with cancer (R)
0.82
Increased spending on cancer services is a waste
of money*
−0.71
The needs of people with cancer should be
given top priority (R)
0.63
We have a responsibility to provide the best
possible care for people with cancer (R)
0.60
Personal responsibility
A person with cancer is liable for their condition 0.81
A person with cancer is accountable for their condition 0.78
If a person has cancer it’s probably their fault 0.73
A person with cancer is to blame for their condition 0.70
Financial discrimination
It is acceptable for banks to refuse to make
loans to people with cancer
0.89
Banks should be allowed to refuse mortgage
applications for cancer-related reasons
0.77
It is acceptable for insurance companies to
reconsider a policy if someone has cancer
0.63
R = Item was reversed.
*Item deleted following CFA.
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not correlated with Severity or Awkwardness.
Internal reliability and test-retest reliability
Internal reliability was adequate for all the factors
(Cronbach’s α = 0.73-0.87). The questionnaire was com-
pleted for a second time by 54% of the respondents (n =
249) and correlations between time 1 and time 2 scores
were significant for all the factors (r = .72-.82, all p’s < .001).
Construct validity
Differences in mean scores for each component by gen-
der, age, subject being studied, belief that lifestyle is the
main cause of cancer, experience of cancer, and social
desirability were explored (reported in Table 3). Female
students had lower means for Personal Responsibility,
Avoidance, Policy Opposition and Financial Discrimin-
ation; indicating lower stigma than male students. Com-
pared with younger students (aged 20–29 years), those
over 30 years had lower Personal Responsibility and
Awkwardness scores. Students studying for life science
or medical qualifications had lower Awkwardness scores
than those studying other subjects (e.g. arts, humanities,
maths, or engineering). Students who believed that life-
style was the main contributor for cancer reported
higher Personal Responsibility than those who did not
rank it as the main contributor. Because close experi-
ence with cancer was quite low in this group, we used
the item relating to ever having been around a person
with cancer as an indicator of some experience with the
illness. Students who had been around someone with
cancer had lower Personal Responsibility and Awkward-
ness scores than those who reported never having been
around someone with cancer, and there was also a trend
towards lower Avoidance in this group (bordering on
significant, p = .057). High social desirability (scoring 6–
10) was associated with lower scores for Avoidance and
Financial Discrimination. Re-running the above analyses
adjusting for social desirability produced very similar re-
sults, with no changes to which independent variables
were significant.
Study 2 – online panel sample
Methods The aim of study 2 was to confirm the factor
structure, as well as the reliability and validity of the
scales in a different sample. Participants were recruited
through an online market research agency (Survey Sam-
pling) which holds a panel of over 200,000 UK residents
who have consented to being contacted by email about
online research studies. Panel members are offered points
which can be exchanged for small rewards (e.g. airmiles).
A random selection of participants were sent an email in-
viting them to take part in our study. Our target was to
Figure 1 Mean scores and standard deviations for each factor across the two studies.
Marlow and Wardle BMC Cancer 2014, 14:285 Page 6 of 12
http://www.biomedcentral.com/1471-2407/14/285recruit at least 200 participants. This was set lower than in
study 1 because there were fewer items by this stage. We
set several quotas to ensure equal numbers of men and
women, younger (<35) and older, and with or without a
university degree. Participants completed the 26 stigma
items, and also the Level of Familiarity (with cancer) ques-
tionnaire [37], and a measure of social desirability [38].
They reported gender, age, education and ethnicity. TheTable 2 Correlations and reliability for each factor
Severity Personal responsibility Awkw
Study 1
Correlations
Personal responsibility .11* - -
Awkwardness .36** .17** -
Avoidance .30** .37** .46**
Policy opposition .00 .28** .04
Financial discrimination .15** .27** .15**
Internal reliability .73 .87 .81
Test-retest reliability .82** .72** .80**
Study 2
Correlations
Personal responsibility .24** - -
Awkwardness .27** .33** -
Avoidance .32** .64** .49**
Policy opposition -.17** .35** .34**
Financial discrimination .19** .37** .25**
Internal reliability .76 .91 .81
*p < .05, **p < .01.study was approved by the UCL Research Ethics Commit-
tee (ref: 0496/007). Confirmatory Factor analysis was run
in Mplus 7.11.
Results Data were collected from 256 participants over
18 days. Half were male (51%) and the mean age was 38
(range 16–80 years). Just under half were single (45%),
44% were married or cohabiting, and the rest wereardness Avoidance Policy opposition Financial discrimination
- - -
- - -
- - -
.21** - -
.23** .35** -
.77 .78 .82
.77** .76** .72**
- - -
- - -
- - -
.39** - -
.43** .23** -
.88 .78 .80
Table 3 Construct validity in the student sample
Severity Personal
responsibility
Awkwardness Avoidance Policy
opposition
Financial
discrimination
Sex
Male 2.78 1.88 2.60 1.55 2.26 2.47
Female 2.84 1.71 2.64 1.41 1.85 2.01
t-test (p value) −0.60 (.552) 2.02 (.044) −0.38 (.704) 2.31 (.022) 4.51 (<.001) 3.58 (<.001)
Age
20-29 years 2.82 1.82 2.72 1.47 1.98 2.20
30+ years 2.82 1.62 2.42 1.39 1.93 2.02
t-test (p value) −0.01 (.992) 2.68 (.008) 3.10 (.002) 1.51 (.132) 0.58 (.561) 1.49 (.137)
Subject studied
Life sciences/medical 2.74 1.74 2.46 1.40 1.95 1.11
Other 2.89 1.77 2.75 1.49 1.98 1.18
t-test (p value) −1.55 (.121) −0.41 (.683) −3.08 (.002) −1.82 (.069) 0.36 (.716) −0.49 (.624)
Belief that lifestyle is cause
No 2.83 1.65 2.62 1.45 2.00 2.12
Yes 2.81 1.95 2.64 1.45 1.90 2.17
t-test (p value) 0.22 (.826) −3.76 (<.001) −0.20 (.838) −0.14 (.886) 1.40 (.163) −0.40 (.692)
Ever been around a person with cancer
Yes 2.81 1.71 2.59 1.43 1.94 2.13
No 2.88 2.00 2.85 1.56 2.08 2.23
t-test (p value) -.58 (.563) −2.81 (.005) −2.15 (.032) −1.91 (.057) 1.40 (.163) −0.66 (.511)
Social desirability
Low score (0–5) 2.83 1.79 2.66 1.50 2.01 2.26
High score (6–10) 2.81 1.73 2.59 1.40 1.91 2.01
t-test (p value) 0.22 (.827) 0.85 (.397) 0.83 (.409) 2.09 (.037) 1.43 (.154) 2.22 (.027)
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All participants had at least some educational qualifica-
tions: 27% indicated basic school-based exams (GCSEs) as
their highest qualification, 30% had A-levels or a qualifica-
tion below degree, and 29% had a university degree. The
majority were from white ethnic backgrounds (80%). Very
few had lived with someone who had cancer (9%), pro-
vided services to people with cancer (6%), or had experi-
enced cancer themselves (4%). About three quarters (72%)
reported that a closeb friend or family member had had
cancer, and only 22% said they had never been around
anyone with cancer. Cases where more than 20% of the 66
variables were missing were excluded from further ana-
lysis (n = 16).
Confirmatory factor analysis
The 26 stigma items were entered into a six-factor con-
firmatory factor analysis (CFA) model. Indicators of each
factor only loaded on their own factor. Measurement
errors between indicators were assumed to be uncorrelated,but factors were allowed to correlate with each other.
Z-scores for skewness and kurtosis were significant for
some items (−10.73 to 11.65 and −2.95 to 11.94 respect-
ively) so a robust maximum likelihood model (MLM)
was used. We considered multiple measures of model fit
using criteria [44]; CFI and TLI (>0.90), SRMR (>0.06)
in combination with RMSEA (>0.05). In the first model,
some of the parameters suggested a poor fit (CFI and
TFI < .09, see Table 4), so the modification indices were
closely inspected. On the basis of inspection, one item
was removed because it loaded onto several factors (In-
creased spending on cancer services is a waste of money)
and correlated residual errors were allowed between two
items within the Awkwardness factor (I would feel at ease
around someone with cancer and I would feel comfortable
around someone with cancer). The close similarity in word-
ing of these two items could explain the significance of
their correlated residual errors. In the final model (χ2SB
(259) = 379.624, p < .001), which included 25 items
and 6-factors there was an improved fit; CFI = 0.942,
Table 4 Results of confirmatory factor analyses testing the generalizability of a 6-factor model of cancer stigma (n = 169)
Model Items χ2SB df CFI TFI SRMR RMSEA
1. Unconstrained 26 562.80*** 284 0.86 0.86 0.087 0.076
2. 1 item excluded1 25 464.00*** 260 0.90 0.89 0.071 0.068
3. 1 item excluded1 and
correlated residuals allowed2
25 379.63*** 259 0.94 0.93 0.064 0.052
1Item excluded from the Policy Opposition factor (Increased spending on cancer services is a waste of money) because the modification indices suggested it also
loaded well onto several other factors.
2Correlated residuals were allowed between I would feel at ease around someone with cancer and I would feel comfortable around someone with cancer.
***p<.001.
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dised factor loadings ranged from 0.45-0.90 and were
all significant at p < .001.
Means, correlations and internal reliability
Scores for each factor were calculated in the same way as
study 1, and the means and standard deviations are shown
in Figure 1 (NOTE: for study 2 the Policy Opposition
Score was based on 3 rather than 4 items). The pattern of
inter-correlations between factors was largely similar to
study 1 (see Table 2), ranging from small to medium for
most pairs (r = −.17-.49), but large for Personal Responsi-
bility and Avoidance (r = .64). Internal reliability ranged
from adequate to good (Cronbach’s α = 0.76-0.91).
Construct validity
Differences in mean scores for each component by gen-
der, age, belief that lifestyle is the main cause of cancer,
experience of cancer and social desirability were ex-
plored (reported in Table 5). Women had lower means
for Avoidance and Policy Opposition, there was also a
tendency towards lower Personal Responsibility (border-
ing on significant, p = .059). Older age was associated
with lower Personal Responsibility, Awkwardness, Avoid-
ance, Policy Opposition and Financial Discrimination.
Participants from ethnic groups other than white-British
scored higher on Personal Responsibility, Avoidance, Policy
Opposition and Financial Discrimination. Higher educa-
tional level was associated with higher Policy Opposition
scores. Participants who reported that a friend or family
member they were close to had had cancer scored lower
on Awkwardness. High social desirability was associated
with reporting lower Awkwardness, Avoidance, Policy Op-
position and Financial Discrimination. We repeated the
above analyses controlling for social desirability. Age was
no longer associated with Avoidance or Financial Discrim-
ination, but all other findings remained significant.
Discussion
This paper reports the development and validation of the
Cancer Stigma Scale (CASS) designed to assess cancer
stigma. The final scale includes 25 items assessing six differ-
ent aspects of stigma; Awkwardness, Avoidance, Perceivedseverity, Policy Opposition, Personal Responsibility and
Financial Discrimination. These components cover a
range of aspects that are moderately correlated with one
another, show adequate to good levels of internal and test-
retest reliability, and fit well with the stigma literature.
Mean scores were similar in the student and online-panel
samples, supporting the validity of the scales.
The severity factor included items relating to how se-
vere the consequences of a cancer diagnosis were ex-
pected to be and the likelihood of recovery from cancer.
This fits well with Jones et al.’s [18] ‘course’ component
and the ‘stability’ component identified by Weiner et al.
[20]. Similarly, Sontag [45] identified the feeling of dread
as a contributor to stigmatisation, stating that “treating
cancer as no mere disease but a demonic enemy makes
cancer not just a lethal disease but a shameful one” (p.59).
The severity factor assesses the belief that a cancer diag-
nosis is catastrophic. Responses on the severity subscale
may be amenable to change following raised awareness of
the success of cancer treatments.
Personal Responsibility, which relates to how much a
person’s actions are considered to have contributed to
their cancer, has consistently been identified in stigma
theory (sometimes referred to as ‘origin’ or ‘controllability’).
Attributions of personal responsibility are made because
the perceiver feels the need to explain why an event (in this
case a diagnosis of cancer) has occurred [46], and some
theories suggest that perceivers attribute responsibility to
individuals to seek justification as to why they are experi-
encing illness (justification ideologies) [47]. Scores on the
Personal Responsibility scale may increase as the public be-
comes more aware about lifestyle risk factors for cancer.
The cancer stigma scale also assessed Awkwardness,
i.e. whether people feel comfortable around someone
with cancer. Items tapping this aspect of stigma have been
used in previous studies [45-47]. Anticipated awkwardness
could be one reason why people would avoid interact-
ing with someone that had cancer, and this is supported
by the moderate correlation between Awkwardness and
Avoidance (r = .43-.46). We found that people who re-
ported more contact with someone who had had cancer
had lower Awkwardness scores, suggesting some adapta-
tion. Interventions designed to decrease the stigma of
Table 5 Construct validity in the non-student sample
Severity Personal
responsibility
Awkwardness Avoidance Policy
opposition
Financial
discrimination
Sex
Male 3.23 2.03 2.84 1.86 2.14 2.50
Female 3.45 1.78 2.78 1.52 1.83 2.34
t-test (p-value) −1.77 (.077) 1.89 (.059) 0.47 (.643) 2.98 (.003) 2.59 (.010) 0.98 (.327)
Age
16-34 years 3.42 2.17 3.18 1.83 2.30 2.65
35-54 years 3.42 1.61 2.61 1.69 1.86 2.36
55+ years 3.13 1.66 2.29 1.44 1.51 2.06
Anova (p-value) 2.03 (.133) 8.45 (<.001) 17.18 (<.001) 4.16 (.017) 17.08 (<.001) 4.91 (.008)
Education*
School level - low 3.55 1.72 2.68 1.56 1.67 2.42
School level - high 3.32 1.92 2.78 1.65 2.00 2.32
University level 3.17 2.07 3.01 1.82 2.33 2.55
Anova (p-value) 2.61 (.076) 2.06 (.131) 1.60 (.204) 1.74 (.179) 8.72 (<.001) 0.63 (.532)
Ethnicity
White 3.29 1.78 2.74 1.63 1.87 2.32
Other 3.57 2.44 3.06 1.96 2.45 2.87
t-test (p-value) −1.79 (.075) −3.40 (.001) −1.81 (.071) −2.34 (.020) −3.79 (<.001) −2.74 (.007)
Close friend or family member has had cancer
No 3.53 1.93 3.12 1.85 2.14 2.66
Yes 3.28 1.90 2.70 1.64 1.93 2.34
t-test (p-value) 1.80 (.073) 0.18 (.858) 2.65 (.009) 1.64 (.103) 1.48 (.140) 1.69 (.093)
Social desirability
Low score (0–5) 3.43 2.01 3.19 1.90 2.19 2.70
High score (6–10) 3.28 1.82 2.51 1.53 1.82 2.20
t-test (p-value) 1.17 (.242) 1.45 (.149) 5.11 (<.001) 3.21 (.002) 3.01 (.003) 3.12 (.002)
*Low school level = GCSEs as their highest qualification, High school level = A-levels or a qualification below degree.
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have these illnesses is one of the most effective strategies
[48]. Future work could consider the effect of similar in-
terventions on perceived awkwardness around someone
with cancer.
Avoidance, Policy Opposition and Financial Discrimin-
ation were also included in the scale. Goffman believed
when a trait turns “those of us whom he meets away
from him”, a person is the victim of stigmatisation in its
purest form (p.15) [1], and this strongly supports the ex-
istence of the Avoidance component that is included in
the scale. Avoidance items have also been included in
many other studies that have assessed stigma of other ill-
nesses e.g. [49-51].
The items on Financial Discrimination also fit well with
studies in the context of other illnesses [29]. There are
some legal boundaries in place to limit unfair discrimin-
ation against cancer patients (e.g. in the work-place), but
in other instances discrimination is still acceptable (e.g.for obtaining travel insurance). While the estimation of a
high chance of needing medical care is accurate in some
cases, this is not always the case and making judgments
on the basis of a cancer label alone, rather than an indi-
vidual diagnosis, may not be considered fair. Financial
worries can be an additional cause of stress following a
cancer diagnosis, and fear of stigma can lead to patients
avoiding claiming the financial benefits they are entitled
to [52]. Understanding public opinion about such dis-
crimination and how this correlates with other stigma
components is an area for future research. The Policy
Opposition component was correlated with Financial
Discrimination. Although these sorts of items are less
common in other stigma scales, they allowed us to in-
clude items tapping positive attitudes towards people
with cancer.
Many of the stigma components were associated with
socio-demographic factors. For the most part, being male
was associated with higher cancer-related stigma (higher
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position and Financial Discrimination in at least one of
the samples), as was younger age (higher scores for Per-
sonal Responsibility, Awkwardness, Avoidance, Policy Op-
position and Financial Discrimination in at least one of
the samples). In study 2, we also looked at ethnicity and
education level. Being from an ethnic group other than
white-British was associated with greater stigma (higher
personal Responsibility, Avoidance, Policy Opposition, and
Financial Discrimination) while being more educated was
associated with higher Policy Opposition scores, but no
other component.
Scoring higher on social desirability was associated with
lower cancer-related stigma (lower Awkwardness, Avoid-
ance, Policy Opposition and Financial Discrimination).
This suggests that those who care more strongly about
what others think of them are motivated to deny negative
attitudes towards cancer patients. This association could
suggest that participants may not be truthful when asked
about cancer stigma and this has important implications
for using the scale we have developed. We selected an
internet-based survey to overcome the effects of social de-
sirability, but it remained nevertheless and may have an
even stronger influence if alternative collection methods
were used.
There are other aspects of stigma theory that are not
included in the CASS, for example we have not assessed
the influence of concealability, disruptiveness or aesthet-
ics; three components that are associated with the visible
aspects of illness [19]. That is not to say they are irrele-
vant, but these other aspects may be specific to certain
cancers/treatments (e.g. disfigurement following head and
neck cancer), and in the interests of developing a brief,
valid scale, we felt it best to focus on the most salient as-
pects of cancer stigma generally.
We acknowledge a number of limitations. As with all
scales, the CASS is limited by the quality of the initial
item pool. We attempted to ensure items had good face
validity and covered all aspects identified by stigma theory
by using items from previously validated measures and in-
cluding several steps prior to factor analysis. Although our
studies had adequate participants item ratios (1:7 for study
1 and 1:9 for study 2) in accordance with some criteria,
others might recommend higher sample sizes. For con-
venience, we choose to use a student sample for the first
part of this study. There are obvious limitations to the use
of this sample, most notably their age and education level
are not reflective of the general population. We did ex-
pand our work to include a general population sample
following exploratory factor analysis, but neither of our
studies was carried out in a representative sample, so the
mean scores may not reflect those in the general popula-
tion. In addition, using online administration means those
who do not have access to or use computers were excluded.Regular internet use is associated with higher income [53]
and our online panel sample (study 2) could reflect this.
Although there were a range of responses across the
two samples, the results, particularly for some of the fac-
tors, were highly skewed. This is not surprising given the
two samples were quite homogenous and we may expect
more normally distributed responses if the data were col-
lected in the general population. Severity scores did not
vary by any of the variables measured which could suggest
poor content validity or a very limited range of results.
Future research should recruit samples that are ex-
pected a priori, to have high or low feelings of stigma.
While this paper did consider experience of cancer, recruit-
ing groups with particularly high levels of experience such
as oncology nurses may generate more variation.
As is the case with development of any measure, our
findings regarding the validity, reliability and structure
of the CASS are limited to the context within which our
data were collected. Additional work is needed to validate
the CASS in different population sub-groups (e.g. ethnic
minorities, lower literacy populations) and in different
countries. Cancer is highly stigmatised in some cultures
and the availability of a validated scale which could be
used cross-culturally would be particularly useful.
Considering differences across cancers would also be
interesting. The term cancer incorporates many diseases,
and it is likely that some cancers are seen differently from
others. We found that participants who rated lifestyle as
the main contributing risk factor for cancer score more
highly on the Personal Responsibility sub-scale. However,
the conclusions we can draw from this are limited because
the aetiology of each cancer is different. Previous work
has shown that some cancers with an established behav-
ioural aetiology attract greater blame attributions [22],
and studies with patients and health professionals, suggest
lung cancer attracts more stigma than other cancers as
a result of its link with a behavioural cause (smoking)
and poor prognosis [11]. A recent review suggested that
anti-smoking campaigns, may contribute to stigma among
lung cancer patients who smoke [11]. Changes in public
perceptions of cancer stigma following such campaigns
have not yet been assessed and the CASS could be a useful
tool for doing this.Conclusions
This manuscript describes the development and valid-
ation of the CASS, a scale to assess cancer related stigma
in a non-patient population. Stigma was first discussed
in relation to cancer many years ago, but there has been
little systematic research in this area. The availability of a
tool to assess cancer stigma will help to identify if there is
real cause for concern in this area and if so where inter-
ventions designed to decrease stigma are needed.
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aCognitive interview procedures might be recommended
at this stage, but given that our items were generated from
previous work we felt it was acceptable to proceed with-
out this.
bBecause such a high proportion of participants in study
1 had indicated that a friend or family member had had
cancer, these questions were changed slightly for study 2, so
that they referred specifically to ‘close’ friends or relatives.
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